During the nine months ended June 30, 2025, 178,700 restricted stock units, 135,300 performance share units, and 12,000 stock options were granted to directors, executive officers and certain managers of the Company. During the nine months ended June 30, 2025, performance share units granted in December 2022 were reduced by 10,200 units, according to the targeted performance formula. The awards were made pursuant to the Amended and Restated 2008 Equity Incentive Plan, which was approved at the annual meeting of shareholders held on February 22, 2018.

The following table presents share-based compensation expense recognized during the periods presented:


	For the Three Months Ended				For the Nine Months Ended
	June 30,				June 30,
	2025		2024		2025		2024
Stock option expense	$	28	$	31	$	84	$	54
Restricted stock units expense	654		584		1,973		2,216
Performance share units expense	265		225		745		656
Total stock-based compensation expense	$	947	$	840	$	2,802	$	2,926

At June 30, 2025, 1,230,475 shares were subject to options, with a weighted average exercise price of $15.81 per share and a weighted average grant date fair value of $1.94 per share. Expected future expense, relating to the 258,600 non-vested options outstanding as of June 30, 2025, is $154 over a weighted average period of 1.4 years. At June 30, 2025, 421,990 restricted stock units and 288,100 performance share units with a weighted average grant date fair value of $13.13 and $13.01 per unit, respectively, are unvested. Expected future compensation expense, relating to the 1,187,738 restricted stock units and 288,100 performance share units outstanding as of June 30, 2025, is $3,094 over a weighted average period of 1.9 years and $1,515 over a weighted average period of 2.0 years, respectively. Each unit is equivalent to one share of common stock.